unit
describ
protocol
develop
hepatocytelik
cell
hlc
start
mesenchym
stem
cell
msc
natur
host
hepat
c
viru
hcv
includ
prepar
msc
bone
marrow
reprogram
msc
induc
pluripot
stem
cell
ipsc
differenti
ipsc
hlc
unit
also
incorpor
character
result
cell
stage
anoth
section
entail
prepar
hcv
sourc
hcv
either
clinic
isol
hcv
hcvser
convent
genotyp
last
section
infect
protocol
coupl
measur
viral
titer
c
john
wiley
son
inc
keyword
cellular
reprogram
r
hepat
c
viru
hcv
r
hepatocytelik
cell
hlc
r
induc
pluripot
stem
cell
ipsc
r
mesenchym
stem
cell
msc
r
r
hcvcc
r
hcvser
human
primari
hepatocyt
ideal
natur
host
cell
livertarget
pathogen
hepat
b
kaneko
et
al
hepat
c
sangiamsuntorn
et
al
malari
parasit
ng
et
al
dengu
virus
lang
vera
cheng
tang
difficulti
obtain
cell
limit
life
span
restrict
studi
long
term
hostpathogen
interact
xenobiot
metabol
hepat
c
viru
singl
positivestrand
rna
viru
belong
genu
hepaciviru
flavivirida
famili
simmond
et
al
chronic
hcv
infect
led
cirrhosi
hepatocellular
carcinoma
chisari
estim
million
peopl
global
chronic
hcv
infect
effect
vaccin
protect
hcv
recent
treatment
hcv
use
directact
antivir
daa
drug
sofosbuvir
simeprevir
could
erad
hcv
infect
howev
sever
daa
drug
resist
report
imhof
simmond
jazwinski
muir
develop
effect
hcv
cultur
model
critic
design
efficaci
antihcv
strategi
studi
hcv
life
cycl
antihcv
drug
reli
human
hepatocellular
carcinoma
cell
line
deriv
clone
hcv
genotyp
could
propag
deriv
cell
catanes
dorner
wakita
et
al
applic
hepatocellular
carcinoma
cell
host
hcv
could
fulli
mimic
primari
human
hepatocyt
genotyp
phonotyp
cancer
cell
abnorm
cell
also
lose
contact
inhibit
dissimilar
primari
hepatocyt
mostli
present
quiescent
stage
hepatocellular
carcinoma
cell
usual
lack
sever
liver
enzym
eg
phase
ii
drug
transport
make
inadequ
antihcv
drug
screen
human
induc
pluripot
stem
cell
ipsc
reprogram
somat
cell
ectop
express
cmyc
takahashi
yamanaka
takahashi
et
al
cell
activ
enter
cellular
divis
differenti
function
hepatocytelik
cell
hlc
chun
byun
lee
lineag
applic
hlc
deriv
either
ipsc
embryon
stem
cell
natur
host
hcv
recent
report
schwartz
et
al
sitayeb
et
al
differenti
cell
express
essenti
liver
function
achiev
matur
hepatocyt
hlc
also
express
known
hcv
host
receptor
involv
hcv
entri
occludin
srbi
support
complet
life
cycl
classic
hcv
genotyp
day
sangiamsuntorn
et
al
wu
et
al
hlc
promptli
taken
hcv
host
infect
cell
could
host
full
viral
life
cycl
transfectioninfect
hcvcc
hcvser
hlc
could
sustain
replic
hcv
variou
wildtyp
hcv
deriv
patient
sera
unit
describ
overal
procedur
gener
hepatocytelik
cell
natur
host
hepat
c
viru
product
drug
metabol
unit
begin
basic
protocol
explain
procedur
isol
human
mesenchym
stem
cell
msc
aspir
bone
marrow
basic
protocol
describ
mainten
cultur
isol
msc
lentivir
particl
carri
reprogram
factor
cmyc
produc
use
plasmid
cotransfect
describ
basic
protocol
gener
ipsc
msc
use
precursor
cell
cellular
reprogram
follow
basic
protocol
ipsc
character
variou
method
alkalin
phosphatas
stain
immunofluoresc
stain
pluripot
gene
express
use
revers
transcript
pcr
seri
ipsc
character
method
describ
basic
protocol
basic
protocol
describ
hepat
induct
ipsc
function
hepatocytelik
cell
basic
protocol
describ
character
differenti
cell
use
follow
method
period
acidschiff
stain
glycogen
hepatocyteselect
gene
express
realtim
qpcr
activ
luciferasebas
assay
cellular
hepat
c
receptor
hlc
immunofluoresc
stain
basic
protocol
describ
applic
hlc
host
hcv
infect
replic
basic
protocol
demonstr
infect
titer
either
hcvcc
hcvser
hlc
moment
hlc
serv
host
cell
wildtyp
hcv
hcvser
follow
procedur
perform
class
ii
biolog
hazard
flow
hood
laminarflow
hood
note
solut
equip
come
contact
live
cell
must
steril
proper
asept
techniqu
use
accordingli
note
incub
perform
humidifi
co
incub
unless
otherwis
specifi
note
cell
cultur
reagent
list
store
reconstitut
use
specifi
product
data
sheet
suppli
manufactur
unless
specif
state
note
recombin
protein
chemic
inhibitorsactiv
store
reconstitut
human
mesenchym
stem
cell
msc
isol
aspir
bone
marrow
healthi
donor
protocol
describ
procedur
separ
fraction
mononuclear
cell
use
ficol
densiti
gradient
centrifug
ficol
neutral
highli
branch
highmass
hydrophil
polysaccharid
dissolv
readili
aqueou
solut
centrifug
mononuclear
cell
seed
msc
appear
within
day
two
week
seed
msc
display
spindleshap
morpholog
figur
pure
popul
msc
obtain
passag
subcultur
phosphatebuff
salin
dpb
without
calcium
magnesium
ficol
ge
healthcar
life
scienc
transfer
bone
marrow
aspir
ml
centrifug
tube
dilut
bone
marrow
pb
ratio
reconstitut
volum
ml
two
conic
centrifug
tube
add
ml
ficol
hypaqu
reagent
isoprep
follow
gentl
overlay
ml
dilut
bone
marrow
isoprep
solvent
phase
junction
isoprep
layer
bone
marrow
layer
disrupt
centrifug
solut
min
g
brake
centrifug
mononuclear
cell
layer
would
present
white
ring
interfac
isoprep
layer
bottom
dilut
bone
marrow
layer
top
white
ring
could
collect
immedi
use
steril
pasteur
pipett
transfer
new
conic
centrifug
tube
collect
white
ring
solut
remov
plasma
solut
upper
layer
aspir
gentli
pipett
white
ring
solut
contain
mononuclear
cell
conic
centrifug
tube
cell
densiti
seed
cell
per
one
cell
cultur
flask
transfer
cell
suspens
cell
cultur
flask
incub
cell
suspens
humidifi
incub
co
replac
cultur
medium
first
time
day
follow
everi
day
thereaft
day
adher
cell
could
appear
show
spindleshap
morpholog
observ
invert
microscop
coloni
clearli
observ
cultur
surfac
possibl
contamin
cultur
cell
hematopoiet
cell
red
blood
cell
blood
stem
cell
could
elimin
success
cell
passag
msc
cell
character
immunostain
cell
popul
analyz
use
flow
cytomet
wongkajornsilp
sangiamsuntorn
hongeng
protocol
aim
propag
msc
experi
frozen
storag
isol
msc
enzymat
passag
follow
protocol
time
without
acquisit
cellular
senesc
maximum
passag
life
span
cultur
msc
could
vari
depend
individu
donor
optim
time
harvest
msc
earli
passag
rd
th
precursor
cell
cellular
reprogram
human
msc
flask
see
basic
protocol
phosphatebuff
salin
dpb
without
calcium
magnesium
inactiv
trypsin
ad
ml
msc
cultur
medium
fb
supplement
fb
penicillin
streptomycin
flask
gentli
resuspend
detach
cell
transfer
reconstitut
conic
centrifug
tube
centrifug
min
g
discard
supernat
cell
pellet
resuspend
ml
prewarm
msc
cultur
medium
fb
supplement
fb
penicillin
streptomycin
mix
cell
suspens
trypan
blue
count
hemacytomet
cell
viabil
greater
msc
cell
densiti
per
flask
around
cell
incub
cell
co
replac
msc
cultur
medium
twice
week
subcultur
week
msc
earli
passag
ie
st
th
cryopreserv
liquid
nitrogen
longterm
use
protocol
describ
product
lentivir
vector
deliv
reprogram
gene
oskm
increas
safeti
lentiviru
essenti
compon
viral
product
split
multipl
plasmid
three
nd
gener
rd
gener
system
compon
reprogram
vector
follow
lentivir
transfer
plasmid
encod
cmyc
sequenc
insert
ltr
region
enabl
host
genom
integr
packag
plasmid
envelop
plasmid
procedur
produc
infecti
transgen
lentiviru
consist
cotransfect
three
four
plasmid
cell
b
collect
condit
medium
contain
viru
c
purif
concentr
viru
concentr
viru
use
infect
msc
biosafeti
alway
consid
respect
precis
natur
experi
perform
biosafeti
offic
provid
inform
institut
best
practic
regard
manipul
infecti
viru
nih
also
addit
inform
lentivir
safeti
consider
plasmid
concentr
measur
use
nanodrop
spectrophotomet
could
adjust
appropri
concentr
approxim
hr
transfect
seed
cell
densiti
cell
ml
dmem
fb
penicillin
streptomycin
onto
cultur
dish
gentli
shake
cell
cultur
dish
side
side
evenli
distribut
cell
monitor
confluenc
daili
transfect
cell
adher
cell
confluent
cell
detach
transfect
observ
use
cell
cultur
dish
precoat
polydlysin
prior
seed
transfect
lentivir
plasmid
packag
cell
transfect
day
gentli
remov
cultur
medium
cell
cultur
dish
replac
ml
dmem
supplement
fb
penicillin
streptomycin
steril
microcentrifug
tube
add
prrlpptsfhoksm
idtomatoprefrt
equival
mix
thoroughli
pmdlgprre
gag
pol
plasmid
prsvrev
rev
plasmid
vesicular
stomat
viru
g
envelop
plasmid
addgen
adjust
total
volum
use
optimem
medium
microcentrifug
tube
add
optimem
medium
xtremegen
hp
dna
transfect
reagent
mix
pipet
time
undilut
xtremegen
hp
dna
transfect
reagent
pipet
directli
optimem
medium
without
contact
side
microcentrifug
tube
may
reduc
transfect
effici
gentli
mix
plasmid
solut
step
solut
step
pipet
incub
transfect
reagentdna
complex
min
room
temperatur
add
solut
condit
onto
cultur
dish
drop
drop
use
micropipett
cover
entir
cultur
area
incub
transfect
complex
packag
cell
cell
cultur
dish
co
overnight
hr
approxim
hr
transfect
replac
cell
cultur
medium
ml
dmem
fb
contain
penicillinstreptomycin
incub
co
isol
lentivir
particl
cultur
supernat
hr
transfect
harvest
condit
medium
use
syring
filter
filter
remov
cell
debri
concentr
lentiviru
add
volum
lentix
concentr
volum
clarifi
supernat
step
gentli
mix
solut
invers
incub
mixtur
hr
centrifug
solut
hr
centrifug
offwhit
pellet
visibl
lentiviru
condit
medium
concentr
sucros
gradient
ultracentrifug
use
wv
sucros
hr
g
gentli
reconstitut
pellet
dulbecco
phosphatebuff
salin
dpb
store
year
singleus
aliquot
pleas
avoid
freez
thaw
lentiviru
one
time
freezethaw
cycl
reduc
viral
infect
titer
sever
type
cell
use
gener
ipsc
transduc
reprogram
factor
common
somat
cell
extens
reprogram
fibroblast
howev
human
fibroblast
limit
short
life
span
genet
instabl
requir
expans
sever
passag
reprogram
human
msc
multipot
stem
cellderiv
aspir
bone
marrow
passag
time
without
genet
instabl
gene
mutat
protocol
describ
procedur
infect
msc
lentiviru
carri
cmyc
includ
select
marker
dtomato
transduc
msc
observ
red
fluoresc
dtomato
form
coloni
day
posttransduct
fulli
reprogram
coloni
select
stain
coloni
observ
silenc
dtomato
th
passag
ipsc
transfer
feederfre
cultur
medium
use
precursor
cell
hepatocyt
differenti
plate
cell
cultur
dish
stereomicroscop
dish
reprogram
msc
ipsc
one
day
infect
seed
msc
cell
well
plate
fig
b
infect
msc
lentiviru
moi
spinfect
centrifug
min
g
msc
growth
medium
supplement
fb
penicillin
streptomycin
contain
polybren
hr
postinfect
replac
medium
ml
msc
growth
medium
without
polybren
maintain
infect
msc
cultur
medium
day
add
mm
sodium
butyr
cultur
medium
day
postinfect
ad
sodium
butyr
valproic
acid
solut
transduc
msc
could
enhanc
cellular
reprogram
day
split
infect
msc
plate
plate
onto
cell
cultur
dish
preseed
mitomycin
cinactiv
mous
embryon
fibroblast
imef
feeder
cell
densiti
cellscm
maintain
infect
cell
msc
growth
medium
hr
fig
figur
ipsc
coloni
livestain
antibodi
pluripot
surfac
marker
ipsc
coloni
grown
mef
day
transduct
livestain
antibodi
follow
alexa
conjug
goat
anti
mous
igg
coloni
verifi
fluoresc
microscop
b
dtomato
disappear
ipsc
c
ipsc
geltrex
exhibit
high
nucleasetocytoplasm
ratio
promin
nucleoli
immunofluoresc
stain
nanog
follow
alexa
fluor
conjug
secondari
antibodi
confirm
ident
ipsc
reprogram
msc
e
nuclei
local
dapi
blue
scale
bar
express
pluripot
marker
determin
rtpcr
ipsc
exhibit
similar
express
profil
pluripot
marker
embryon
stem
cell
esc
g
pick
eslik
coloni
use
stereomicroscop
biosafeti
cabinet
avoid
contamin
transfer
individu
coloni
singl
reprogram
cell
onto
well
plate
order
get
ident
ipsc
line
perform
preliminari
identif
reprogram
cell
stain
coloni
antihuman
antibodi
dilut
ipsc
medium
min
co
incub
incub
gentli
wash
coloni
ml
pb
add
alexa
fluor
goat
antimous
igg
andor
igm
dilut
incub
min
wash
coloni
twice
time
ml
ipsc
medium
fig
observ
coloni
stereomicroscop
mark
coloni
draw
circl
bottom
plate
perman
pen
subcultur
th
passag
ip
coloni
pick
maintain
feederfre
cultur
use
geltrex
coatedpl
medium
hous
medium
daili
medium
replac
fig
transfer
ipsc
feederfre
condit
cultur
ipsc
yield
viabl
coloni
feederfre
condit
passag
ipsc
incub
dilut
versen
solut
mm
edta
min
round
cell
appear
remov
edta
solut
reconstitut
ipsc
medium
plu
seed
onto
new
geltrexco
dish
ipsc
cell
reach
confluenc
prior
subcultur
screen
spontan
differenti
cell
use
invert
microscop
mark
remov
coloni
subcultur
avoid
bring
ipsc
sinc
spontan
differenti
ensu
humaninduc
pluripot
stem
cell
ipsc
character
sever
method
pluripot
gene
express
alkalin
phosphatas
activ
silenc
exogen
reprogram
factor
immunostain
pluripot
marker
karyotyp
analysi
vitro
vivo
differenti
howev
method
timeconsum
labor
intens
unit
describ
recommend
screen
protocol
ipsc
includ
three
fundament
method
rapidli
character
ipsc
alkalin
phosphatas
ap
activ
immunofluoresc
stain
cultur
ipsc
day
prior
measur
ap
activ
low
medium
cell
densiti
day
aspir
medium
fix
ipsc
pfa
fix
solut
min
aspir
fix
rins
ml
rins
buffer
add
enough
naphtholfast
red
violet
solut
fulli
cover
well
eg
ml
well
plate
incub
min
dark
room
temperatur
aspir
stain
solut
rins
well
ml
rins
buffer
cover
cell
pb
prevent
dri
count
number
coloni
express
ap
red
ipsc
coloni
use
phasecontrast
invert
microscop
fig
cultur
ipsc
five
day
prior
analyz
pluripot
protein
low
medium
cell
densiti
primari
antibodi
use
ipsc
character
follow
nanog
alpha
fetoprotein
afp
alphasmooth
muscl
actin
tubulin
dilut
primari
antibodi
block
solut
incub
ipsc
coloni
overnight
wash
coloni
three
time
time
ml
pb
extract
total
rna
ipsc
use
illustra
rnaspin
mini
kit
dnase
treatment
covert
ng
total
rna
cdna
use
oligodt
primer
impromii
revers
transcript
system
follow
manufactur
instruct
dilut
cdna
ratio
use
templat
pcr
reaction
mix
dilut
cdna
pcr
master
mix
solut
contain
fast
hotstart
readymix
pcr
kit
pluripot
gene
primer
see
tabl
amplifi
pcr
product
thermal
cycler
use
temperatur
condit
follow
detect
specif
amplif
pcr
product
use
gel
electrophoresi
agaros
gel
fig
protocol
describ
procedur
deriv
hepatocytelik
cell
hlc
ipsc
use
direct
differenti
differenti
cell
develop
homogen
popul
hepatoblastlik
cell
differenti
function
hepatocyt
fig
protocol
appli
differenti
convent
he
cell
line
hlc
procedur
use
defin
cultur
medium
devoid
serum
nondefin
factor
contain
four
step
mimic
embryon
liver
develop
stage
procedur
begin
expans
ipsc
cell
cultur
plate
follow
first
stage
differenti
protocol
ipsc
differenti
definit
endoderm
cell
second
stage
differenti
cell
develop
anterior
definit
endoderm
cell
third
stage
endoderm
cell
turn
hepat
progenitor
fourth
stage
hlc
undergo
function
matur
exhibit
liver
specif
marker
albumin
secret
glycogen
storag
cholesterol
metabol
manipul
potenc
bring
ipsc
higher
confluenc
could
decreas
homogen
endoderm
differenti
induc
cell
clump
maintain
cultur
cell
ml
endoderm
commit
medium
imdm
mgml
pva
vv
concentr
lipid
ngml
activin
ngml
bfgf
ngml
insulintransferrinselenium
hr
adjust
optim
concentr
previou
public
use
experi
concentr
induc
cell
death
cultur
endodermlik
cell
ml
anterior
definit
endoderm
differenti
medium
ngml
activin
day
daili
medium
replac
anterior
definit
endoderm
commit
period
medium
chang
everi
hr
third
day
typic
morpholog
cell
undergo
differenti
obtain
fig
maintain
differenti
cell
ml
hepat
lineag
specif
medium
ngml
ngml
day
daili
medium
replac
cultur
differenti
cell
ml
hbm
basal
medium
hbm
ngml
oncostatin
ngml
hgf
day
medium
replac
everi
day
ensur
ipsc
achiev
complet
hepat
differenti
protocol
select
distinct
marker
confirm
hepat
phenotyp
matur
hepatocyt
accumul
glycogen
cytoplasm
measur
use
period
acidschiff
stain
pa
assay
express
select
hepatocyt
marker
eg
albumin
cytokeratin
tyrosin
aminotransferas
cytochrom
could
use
determin
matur
hlc
sangiamsuntorn
et
al
protocol
describ
procedur
use
evalu
hepat
marker
use
quantit
realtim
pcr
benchmark
hlc
primari
hepatocyt
cytochrom
activ
measur
use
luciferasebas
assay
sangiamsuntorn
et
al
result
cell
unit
still
express
signific
level
also
express
marker
adult
hepatocyt
albumin
cytokeratin
tyrosin
aminotransferas
express
activ
increasingli
respond
prototyp
induc
fashion
primari
hepatocyt
last
section
unit
describ
protocol
detect
hepat
c
host
specif
receptor
occludin
srbi
use
revers
transcript
pcr
immunofluoresc
stain
discard
cultur
medium
fix
adher
cell
ml
formaldehyd
min
rins
cell
run
tap
water
min
immers
cell
period
acid
solut
min
rins
sampl
three
time
time
ml
dh
immers
sampl
schiff
reagent
min
rins
run
tap
water
min
counterstain
sampl
ml
mayer
hematoxylin
min
rins
sampl
water
examin
sampl
light
microscop
immedi
construct
cdna
total
rna
use
impromii
revers
transcript
system
follow
manufactur
instruct
total
mrna
store
sever
week
immedi
convert
mrna
cdna
highli
recommend
mrna
stabl
room
temperatur
hepatocyt
marker
cytochrom
marker
albumin
cytokeratin
tyrosin
aminotransferas
major
cyp
isozym
genespecif
primer
includ
hous
keep
gene
gapdh
design
use
vector
nti
version
invitrogen
primer
list
tabl
amplifi
specif
gene
use
kapa
sybr
fast
qpcr
kit
reaction
mix
ng
cdna
master
mix
kapa
sybr
fast
qpcr
kit
pair
specif
primer
amplifi
target
dna
qpcr
system
use
follow
temperatur
profil
first
step
min
second
step
cycl
sec
sec
final
step
melt
curv
analysi
confirm
pcr
amplicon
use
size
melt
curv
analysi
agaros
gel
electrophoresi
need
check
authent
pcr
product
research
use
sybr
green
master
mix
other
supplier
one
run
templat
control
ntc
optim
pcr
condit
calcul
gene
express
level
use
ct
method
normal
endogen
gapdh
express
transform
ct
fold
chang
use
formula
fold
chang
ct
cultur
hlc
heparg
primari
human
hepatocyt
collagen
type
ivcoat
dish
densiti
cellswel
incub
cultur
cell
cocktail
rifampicin
omeprazol
mm
phenobarbit
ethanol
incub
treat
cell
hr
daili
medium
chang
measur
enzym
activ
cultur
cell
use
assay
incub
period
incub
cell
william
medium
e
supplement
luciferince
luciferinh
hr
luciferinipa
min
transfer
medium
opaqu
white
luminomet
plate
add
luciferin
detect
reagent
well
incub
room
temperatur
min
measur
spectrofluoromet
rel
luminesc
unit
rlu
could
calcul
follow
rlu
lu
treatedlu
blank
lu
untreatedlu
blank
monitor
cellular
receptor
essenti
hcv
infect
occludin
srbi
use
quantit
rtpcr
immunofluoresc
techniqu
seed
matur
hlc
plate
maintain
reach
confluenc
william
medium
e
fb
fix
stain
hlc
fluorescentconjug
antibodi
rais
occludin
srbi
describ
section
detect
pluripot
marker
use
immunofluoresc
stain
fig
fulllength
genom
clone
puc
dna
vector
transcript
control
promotor
kato
et
al
length
kb
puc
dna
vector
contain
ampicillin
resist
gene
plasmid
transform
propag
e
coli
medium
ampicillin
propag
hcvcc
purifi
dna
linear
end
hcv
sequenc
restrict
enzym
xbai
synthes
genom
rna
vitro
transcript
hcv
rna
transfect
cell
hlc
allow
hcv
replic
virion
product
viru
releas
medium
titter
infecti
virion
focu
form
unit
ffu
per
ml
hepatocyt
eg
use
produc
hcv
infecti
particl
ffu
ml
transfect
rna
infect
hcvcc
deriv
hepatocellular
carcinoma
isol
japanes
male
welldifferenti
hepatocellular
carcinoma
nakabayashi
taketa
miyano
yaman
sato
hlc
deriv
ipsc
also
host
hcv
product
transfect
rna
infect
hcvcc
usual
produc
ffu
ml
advantag
hlc
natur
host
hcv
productioninfect
nonmalign
origin
capac
produc
higher
hcv
titer
classic
hepatocyt
follow
procedur
unit
describ
hcvcc
propag
protocol
use
cell
hlc
host
viral
product
use
liposomebas
transfect
reconstitut
total
volum
linear
dna
solut
use
te
buffer
ph
add
buffer
phenol
ph
mix
sampl
vigor
use
vortex
mixer
phenol
chloroform
hazard
requir
use
protect
glove
eyewear
centrifug
sampl
min
maximum
speed
room
temperatur
pipett
upper
aqueou
solut
contain
linear
dna
new
microcentrifug
tube
add
one
equal
volum
vv
phenolchloroformisoamyl
alcohol
mix
sampl
vigor
use
vortex
mixer
centrifug
sampl
min
maximum
speed
room
temperatur
pipett
upper
aqueou
solut
contain
linear
dna
new
microcentrifug
tube
add
one
equal
volum
chloroform
mix
sampl
vigor
use
vortex
mixer
centrifug
sampl
min
maximum
speed
room
temperatur
pipett
upper
aqueou
solut
contain
linear
dna
new
microcentrifug
tube
add
volum
sodium
acet
ph
achiev
final
concentr
sodium
acet
add
sodium
acet
ph
sampl
mix
sampl
vigor
use
vortex
mixer
add
one
volum
isopropanol
microcentrifug
tube
mix
sampl
vigor
use
vortex
mixer
dna
sampl
could
precipit
use
volum
ethanol
depend
sampl
volum
maximum
tube
capac
one
volum
could
also
precipit
dna
use
volum
ethanol
incub
plasmid
solut
hr
allow
plasmid
dna
precipit
achiev
complet
precipit
overnight
incub
recommend
dna
less
digest
precipit
dna
centrifug
min
maximum
remov
isopropanol
wash
pellet
ethanol
centrifug
dna
sampl
min
maximum
speed
room
temperatur
discard
ethanol
wash
pellet
ethanol
centrifug
dna
sampl
min
maximum
speed
room
temperatur
discard
ethanol
aspir
leftov
liquid
may
present
tube
air
dri
dna
pellet
room
temperatur
reconstitut
dna
pellet
nucleasefre
water
measur
dna
concentr
use
nanodrop
spectrophotomet
reconstitut
volum
nucleasefre
water
depend
amount
dna
digest
normal
one
microgram
per
microlit
recommend
dna
sampl
could
store
use
transcrib
mrna
linear
plasmid
use
transcriptaid
high
yield
transcript
kit
follow
manufactur
instruct
combin
follow
reaction
compon
room
temperatur
order
describ
new
pcr
tube
mix
transcriptaid
reaction
buffer
atpctpgtputp
mix
linear
dna
transcriptaid
enzym
mix
adjust
total
volum
dnasernasefre
distil
water
mix
sampl
thoroughli
hand
spin
collect
drop
incub
hr
purifi
rna
use
chloroform
extract
ethanol
precipit
rna
add
dnasernasefre
distil
water
sodium
acet
solut
ph
solut
step
mix
thoroughli
use
vortex
mixer
purif
method
includ
limit
method
method
particular
benefit
conveni
effect
way
recov
rna
author
usual
employ
phenolchloroform
extract
isopropanol
precipit
extract
rna
equal
volum
phenol
ph
chloroform
mixtur
add
anoth
equal
volum
chloroform
collect
aqueou
phase
transfer
solut
new
tube
add
volum
ethanol
sampl
precipit
rna
incub
least
min
collect
pellet
centrifug
discard
supernat
rins
pellet
cold
ethanol
reconstitut
rna
dnasernasefre
distil
water
store
rna
longterm
storag
month
day
prior
transfect
seed
hlc
cell
onto
cell
cultur
dish
maintain
cultur
cell
ml
fb
streptomycin
penicillin
optimum
cell
number
depend
number
transfect
perform
transfect
requir
cell
dish
confluenc
hlc
approxim
cell
transfect
day
gentli
remov
cultur
medium
cell
cultur
dish
replac
ml
dmem
fb
steril
ml
microcentrifug
tube
mix
rna
optimem
medium
adjust
total
volum
optimem
medium
anoth
ml
microcentrifug
tube
add
optimem
tube
pipet
xtremegen
hp
dna
transfect
reagent
directli
optimem
pipett
xtremegen
hp
dna
transfect
reagent
directli
microcentrifug
tube
transfect
effici
decreas
gentli
mix
plasmid
solut
step
solut
step
pipet
incub
transfect
reagentdna
complex
min
room
temperatur
add
solut
condit
ml
onto
cultur
dish
drop
drop
use
micropipett
cover
entir
cultur
area
ensur
plasmid
solut
cover
entir
cultur
area
incub
cell
cultur
dish
overnight
hr
co
incub
approxim
hr
transfect
replac
cell
cultur
medium
ml
fb
penicillinstreptomycin
incub
co
collect
condit
medium
everi
day
keep
condit
medium
harvest
within
week
transfect
clarifi
condit
medium
contain
hcvcc
centrifug
min
g
remov
cell
debri
filter
supernat
cellulos
acet
filter
concentr
hcvcc
use
sucros
gradient
ultracentrifug
briefli
mix
one
volum
sucros
solut
volum
condit
medium
centrifug
hr
g
discard
supernat
collect
hcvcc
pellet
transfer
reconstitut
hcvcc
individu
microcentrifug
tube
singl
freezethaw
cycl
store
year
use
hlc
cell
host
hcvcc
deriv
rna
produc
infecti
virion
depend
host
cell
hcv
genotyp
maxim
titer
could
obtain
day
day
hcvccinfect
hlc
cell
moi
ffucel
protocol
aim
produc
hcvcc
start
infecti
virion
instead
classic
transfect
rna
advantag
infect
protocol
classic
transfect
protocol
consist
infect
protocol
simplifi
infect
protocol
spend
less
time
resourc
infect
protocol
allow
higher
titer
hcvcc
protocol
describ
unit
optim
gener
infecti
hcvcc
hlc
cell
cell
normal
produc
hcvcc
titer
rang
ffuml
hlc
produc
higher
titer
rang
ffuml
cell
incap
host
hcv
deriv
patient
serum
hcvser
hlc
readili
host
hcvser
lead
rise
hcv
titer
ffuml
fig
infect
cell
reach
confluenc
within
day
postinfect
collect
condit
medium
transfer
conic
tube
wash
cell
ml
pb
trypsin
cell
use
trypsinedta
pb
add
ml
fb
inhibit
trypsin
activ
reconstitut
trypsin
cell
final
volum
ml
fb
transfer
conic
tube
contain
condit
medium
adjust
volum
ml
add
ml
fb
conic
tube
seed
infect
cell
hlc
ml
fb
streptomycin
penicillin
onto
cell
cultur
dish
mldish
observ
cytopath
effect
cpe
hlc
cell
hcvccinfect
cell
usual
exhibit
cpe
day
postinfect
collect
condit
medium
daili
store
prior
ultracentrifug
maximum
viral
titer
usual
achiev
day
postinfect
harvest
hcvcc
add
ml
fb
streptomycin
penicillin
dish
bring
cultur
cell
incub
condit
cultur
medium
harvest
everi
day
conic
centrifug
tube
viruscontain
medium
store
futur
determin
viral
titer
clarifi
condit
medium
contain
hcvcc
centrifug
min
g
remov
cell
debri
filter
supernat
cellulos
acet
filter
concentr
hcvcc
use
sucros
gradient
ultracentrifug
briefli
mix
one
volum
sucros
solut
volum
condit
medium
centrifug
hr
g
discard
supernat
collect
hcvcc
pellet
transfer
reconstitut
hcvcc
sever
microcentrifug
tube
allow
singl
freezethaw
cycl
store
year
use
viral
infect
measur
sever
techniqu
cytolyt
virus
coronaviru
herp
virus
frequent
use
techniqu
plaqu
assay
cell
cultur
monolay
use
inert
overlay
noninert
overlay
methylcellulos
agaros
cooper
viral
infect
titer
calcul
plaqueform
unit
pfuml
base
number
plaqu
present
cell
monolay
cultur
howev
hcvcc
noncytolyt
viru
form
plaqu
hlc
monolay
hcvcc
could
form
small
foci
hcv
protein
eg
core
antigen
detect
immunofluoresc
stain
pfa
fix
infect
cell
monolay
number
posit
cell
calcul
hcv
infect
titer
focusform
unit
ffuml
protocol
describ
unit
use
immunofluoresc
stain
determin
hcv
core
antigen
hcvinfect
cell
zhong
et
al
hepatocyt
calcul
hcv
titer
focusform
unit
ffuml
fluoresc
microscop
photograph
fig
select
triplic
cultur
well
adequ
number
foci
perform
reliabl
count
author
prefer
select
well
distinct
foci
use
averag
number
foci
triplic
well
calcul
titer
ffuml
use
follow
formula
titer
ffuml
foci
number
factor
hcv
plate
ml
exampl
averag
foci
observ
dilut
infect
hcvcc
ffuml
ffu
ml
ffuml
collect
leftov
hcvposit
sera
chronic
hcv
patient
collect
leftov
blood
specimen
receiv
approv
irb
select
serum
hcv
patient
hcv
load
iuml
infect
hlc
carri
infecti
specimen
follow
nih
institut
guidelin
hcvser
infect
seed
hlc
plate
william
medium
e
fb
reach
confluenc
pretreat
hlc
hr
prior
incub
hcvser
add
patient
serum
ml
cultur
medium
pretreat
hlc
lower
lipid
peroxid
patient
serum
enhanc
hcvser
infect
hr
incub
wash
hlc
five
six
time
time
ml
bsa
pb
reconstitut
ml
william
medium
e
fb
replac
collect
condit
medium
twice
week
one
month
maximum
titer
obtain
day
hlc
infect
hcvser
observ
cytopath
effect
cpe
hlc
hcvserinfect
cell
usual
exhibit
cpe
day
postinfect
syncyti
cell
would
form
within
week
infect
fig
pool
condit
medium
conic
centrifug
tube
filter
filter
remov
cell
debri
use
deioniz
distil
water
recip
unless
otherwis
indic
ml
phosphatebuff
salin
pb
without
calcium
magnesium
prepar
deioniz
doubledistil
h
without
ca
mg
g
bovin
serum
albumin
fraction
v
ml
vv
triton
sigma
cat
ml
fetal
bovin
serum
fb
final
heatinactiv
min
bring
ml
total
volum
pb
without
cacl
mgcl
filter
steril
use
cellulos
acet
filter
store
year
prepar
add
g
methylcellulos
methocel
mc
fluka
biochemika
cat
ml
water
steril
bottl
contain
stir
bar
stir
methylcellulos
partial
goe
solut
hr
heat
methylcellulos
dissolv
cold
solut
steril
autoclav
allow
solut
return
room
temperatur
methylcellulos
solidifi
shake
vigor
break
clump
transfer
overnight
possibl
stir
methylcellulos
gradual
go
solut
store
month
mem
alpha
modif
contain
vv
heatinactiv
fetal
bovin
serum
fb
mm
lglutamin
glutamax
penicillinstreptomycin
add
stock
store
week
g
paraformaldehyd
pfa
ml
phosphatebuff
salin
pb
without
calcium
magnesium
adjust
ph
n
naoh
pfa
well
dissolv
solut
ph
aid
dissolut
heat
solut
fume
hood
let
solut
rise
bring
ml
total
volum
dpb
without
cacl
mgcl
filter
steril
use
filter
wrap
aluminum
foil
store
year
reconstitut
lyophil
bfgf
final
concentr
pb
contain
wv
bovin
serum
albumin
bsa
store
accord
manufactur
instruct
store
year
ml
rpmi
ml
ml
neaa
ml
penicillinstreptomycin
medium
warm
prior
use
store
week
dissolv
dimethyl
sulfoxid
dmso
stock
concentr
mm
store
year
carri
less
express
primari
hepatocyt
retain
sever
fetal
hepatocyt
marker
recent
report
new
model
natur
hcv
infect
use
hlc
identifi
crucial
factor
transfer
protein
requir
hcvser
infect
hlc
reproduc
express
overal
hepat
function
compar
primari
human
hepatocyt
sangiamsuntorn
et
al
collect
bone
marrow
healthi
donor
could
perform
certifi
surgeon
procedur
receiv
approv
irb
immedi
preserv
bone
marrow
heparin
solut
prevent
blood
coagul
shake
tube
disrupt
solvent
interfac
isoprep
solut
dilut
bone
marrow
avoid
low
msc
yield
trypsin
incub
msc
trypsinedta
longer
min
incub
compromis
cell
viabil
cell
passag
optim
split
ratio
msc
earli
passag
could
cryopreserv
liquid
nitrogen
use
msc
latepassag
senesc
stage
passag
cell
sourc
reprogram
msc
latepassag
usual
unstabl
karyotyp
follow
step
unit
perform
class
ii
tissu
cultur
cabinet
lentiviru
requir
use
biosafeti
level
facil
pseudotyp
lentivirus
packag
vector
capabl
infect
human
cell
handl
infecti
viru
follow
institut
guidelin
biosafeti
follow
inform
brief
descript
biosafeti
level
practic
standard
microbiolog
practic
limit
access
work
area
biohazard
warn
sign
post
minim
product
aerosol
decontamin
potenti
infecti
wast
dispos
use
precaut
sharp
eg
syring
blade
biosafeti
manual
defin
need
wast
decontamin
medic
surveil
polici
safeti
equip
biolog
safeti
cabinet
prefer
class
ii
bsclaminar
flow
hood
hepa
filter
use
manipul
agent
caus
splash
aerosol
infecti
materi
exhaust
air
uncircul
ppe
protect
laboratori
coat
glove
face
protect
need
facil
autoclav
avail
wast
decontamin
chemic
disinfect
avail
spill
lentivir
plasmid
prepar
molecular
biolog
grade
reagent
avoid
chemic
contamin
plasmid
verifi
restrict
map
analysi
passag
split
ratio
day
hpsc
confluent
readi
passag
inhibitor
ad
first
day
differenti
endoderm
differenti
take
day
replac
differenti
medium
everi
hr
third
day
hepat
differenti
take
day
hepat
matur
monitor
express
level
afp
albumin
use
quantit
realtim
pcr
particularli
express
express
cell
popul
addit
incub
dmso
william
medium
e
could
increas
express
author
also
found
qualiti
growth
factor
reagent
purchas
commerci
affect
effici
differenti
critic
point
product
infecti
hcvcc
use
vitrotranscrib
hcv
rna
qualiti
quantiti
fulllength
hcv
rna
genom
express
plasmid
vector
contain
promotor
drive
transcript
approxim
kb
rna
genom
howev
transcript
optim
perfect
synthesi
larg
hcv
transcript
author
recommend
vitrotranscript
monitor
gel
electrophoresi
ensur
rna
qualiti
incid
larg
smear
rna
differ
size
rather
